Articles related to PALLIATIVE CARE

“At the end of the day, it’s vital to avoid overuse of opioids—when the harms would outweigh the benefits—but also to avoid underuse.” – Cary P. Gross, MD, Professor of Medicine at YSM

To help patients and clinicians in strategizing about care decisions at the individual level, ASH convened a multidisciplinary panel — which included experts and patient representatives — to form standardized guidelines for newly diagnosed AML in older patients.

Studies on fluid restriction in patients with HF are scarce, and most of the available studies are at high risk of bias. Although power is lacking, there is no evidence indicating that fluid restriction affects mortality or HF hospitalizations, but there is a signal of harm in terms of thirst distress.

“Oncology nurses are uniquely positioned to ensure that people receive appropriate care to manage their distress. Deliberate application of the therapeutic relationship — including building rapport, validating feelings, normalizing the experience of CRD, and allowing for reflection and meaning-making — is a great way to start.” – Jennifer Stevens, PhD, RN, OCN

“Second-line therapy should not be dismissed outright in platinum-refractory or early-relapsing disease. It remains a relevant part of comprehensive care.” — Tingting Tan, MD, PhD, City of Hope

“The SunRISe-2 trial was stopped in advance for futility based on week-18 overall response rate assessment and the totality of the efficacy data. However, the CR rates in both arms are compelling.” — Andrea Necchi, MD, ASCO GU Symposium 2026